Politics & Policy

New cancer drugs offer hope — but at an often staggering cost

New cancer drugs offer hope — but at an often staggering cost

Julie Grabow, an oncologist at the Fred Hutchinson Cancer Center in Seattle, recently prescribed an exciting new therapy for a 60-year-old woman with metastatic breast cancer — Afinitor made by Novartis. There was a catch, though. Novartis is charging $10,000 per month for the drug

Share
January 25, 2012 | 0 Comments More
View: About that McKinsey report… The critics were right

View: About that McKinsey report… The critics were right

Survey that found that the new health reform law would lead one in three employers to drop worker coverage was poorly done, critics say.

Share
June 26, 2011 | 0 Comments More
Rep. Ryan

View: Ryan Plan–an attempt to reduce health care spending, but at a high cost

On paper, the Ryan plan saves the government a lot of money, at least in the long run. But upon closer inspection, the savings turn out to be illusory, cruel or some combination of the two.

Share
April 15, 2011 | 0 Comments More
Repeal and replace — but replace with what?

Repeal and replace — but replace with what?

The Republicans insist they want not just to repeal the Affordable Care Act but also to replace it. But replace it with what, exactly? It’s not an easy question to answer. They’ve have yet to embrace a specific proposal and, rhetorically, they have made contradictory arguments about what they want

Share
January 18, 2011 | 0 Comments More
Deadly Spin: How insurance companies use PR to fight reform

Deadly Spin: How insurance companies use PR to fight reform

Book Review: If last year’s attacks on the health-care reform law seemed familiar, it’s because you’ve seen same the tactics before, writes Wendell Potter in his new book “Deadly Spin: An Insurance Company Insider Speaks Out on How Corporate PR is Killing Health Care and Deceiving Americans”.

Share
December 10, 2010 | 0 Comments More
Go ahead. Repeal health care reform.

Go ahead. Repeal health care reform.

That’s what President Obama should tell Congressional Republicans, says Princeton health economist Uwe E. Reinhardt.

His logic: The GOP would have to come up with its own solutions to the health cost crisis, many of which, he wagers, would look much like parts of the current law.

“I think it would be a healthy thing,” he says.

Share
November 29, 2010 | 0 Comments More
View: Are “death panels” part of health care reform?

View: Are “death panels” part of health care reform?

Comparative effectiveness research provides officials with a mechanism to decide who will receive treatment, which in some cases will mean who lives and who dies.

Share
November 8, 2010 | 0 Comments More
Jon Cohn

View: GOP’s attacks on health law, confusing and incompatible

“To be fair, the Republican argument makes perfect sense if you think like a campaign operative.”

Share
November 8, 2010 | 0 Comments More
Health care reform: Prove it works and we’ll pay

Health care reform: Prove it works and we’ll pay

With reference pricing, to charge Medicare extra companies get three years to show that a new, costly treatment is better than the old one.

Share
October 5, 2010 | 0 Comments More
View: Can health reform reduce costs?

View: Can health reform reduce costs?

Health reform targets wasteful spending — that is, instances where either individuals or the government is paying too much for what some part of the health care industry is providing

Share
September 29, 2010 | 0 Comments More
View: A new era for access to health insurance

View: A new era for access to health insurance

For those of us who have looked forward to the day when better health care access is provided to each and every person, it’s a great, new day.

Share
September 24, 2010 | 0 Comments More
View: GOP ‘repeal and replace’ strategy lacks merit

View: GOP ‘repeal and replace’ strategy lacks merit

Republican proposals will force many people to pay higher premiums, lavish subsidies on the insurance industry and add $100 of billions to the federal debt.

Share
September 20, 2010 | 0 Comments More